Access to anti-retroviral drugs, female in Armenia

Armenia: Access to anti-retroviral drugs, female was 52.0% in 2024. ◆ Volatile

Latest (2024)
52.0%
Change on year
up 6.1%
World rank
116th
of 141 countries
All-time high
52.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, female in Armenia, 2000–2024

02040602000201220242000: 0 %2001: 0 %2002: 0 %2003: 0 %2004: 0 %2005: 2 %2006: 3 %2007: 4 %2008: 4 %2009: 7 %2010: 9 %2011: 10 %2012: 19 %2013: 22 %2014: 24 %2015: 28 %2016: 33 %2017: 39 %2018: 43 %2019: 45 %2020: 44 %2021: 48 %2022: 50 %2023: 49 %2024: 52 %

Source: UNAIDS estimates. Measured in %.

Analysis

In 2024, access to anti-retroviral drugs, female in Armenia stood at 52.0%. That is the highest value across all 25 years on record.

The figure is up 6.1% on the previous year and up 116.7% over ten years.

Over the whole period, access to anti-retroviral drugs, female in Armenia peaked at 52.0% in 2024 and was at its lowest, 0.0%, in 2000.

That places Armenia 116th out of 141 countries with data for 2024, putting it in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, female in Armenia, year by year

Annual values for Access to anti-retroviral drugs, female (%) in Armenia, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 0.0%
2005 2.0%
2006 3.0% +50.0%
2007 4.0% +33.3%
2008 4.0% +0.0%
2009 7.0% +75.0%
2010 9.0% +28.6%
2011 10.0% +11.1%
2012 19.0% +90.0%
2013 22.0% +15.8%
2014 24.0% +9.1%
2015 28.0% +16.7%
2016 33.0% +17.9%
2017 39.0% +18.2%
2018 43.0% +10.3%
2019 45.0% +4.7%
2020 44.0% -2.2%
2021 48.0% +9.1%
2022 50.0% +4.2%
2023 49.0% -2.0%
2024 52.0% +6.1%

Averages by decade

DecadeAverage LowestHighest Years
2000s 2.0% 0.0% 7.0% 10
2010s 27.2% 9.0% 45.0% 10
2020s 48.6% 44.0% 52.0% 5

Countries ranked near Armenia

  1. 114 Latvia 54.0% compare
  2. 114 Venezuela, Bolivarian Republic of 54.0% compare
  3. 116 Libya 52.0% compare
  4. 118 Belize 51.0% compare
  5. 118 Ghana 51.0% compare
  6. 118 Papua New Guinea 51.0% compare
  7. 118 South Sudan 51.0% compare

See the full ranking of 160 places →

More gender data for Armenia

All data for Armenia →

Frequently asked questions

What is access to anti-retroviral drugs, female in Armenia?
Access to anti-retroviral drugs, female in Armenia was 52.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, female recorded in Armenia?
The highest recorded value was 52.0% in 2024.
What is the lowest access to anti-retroviral drugs, female recorded in Armenia?
The lowest recorded value was 0.0% in 2000.
How does Armenia rank for access to anti-retroviral drugs, female?
Armenia ranks 116th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, female rising or falling in Armenia?
Over the last ten years it is up 116.7%. The long-run trend across the full record is volatile.
Where does this Armenia data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, female in Armenia. Statizoid, drawing on UNAIDS estimates. Retrieved 11 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/armenia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/armenia/">Access to anti-retroviral drugs, female in Armenia</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.